"World's Most Complete Market Research Reports Repository"

Global Pulmonary Alveolar Proteinosis (PAP) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 675294
  • |
  • Publishe Date : 6-Nov-18
  • |
  • No of Pages: 106
  • |
  • Publisher : Global Info Research

Pulmonary alveolar proteinosis (PAP), also known as pulmonary alveolar phospholipoproteinosis, is a diffuse lung disease characterized by the accumulation of amorphous, periodic acid-Schiff (PAS)-positive lipoproteinaceous material in the distal air spaces.



Scope of the Report:

This report studies the Pulmonary Alveolar Proteinosis (PAP) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pulmonary Alveolar Proteinosis (PAP) market by product type and applications/end industries.

Treatment of PAP depends on the form of PAP and age of a patient with PAP and severity of the disease.?WLL is a standard treatment for PAP and the only treatment which has shown improved symptoms and oxygenation in patients.?Another treatment of PAP includes using recombinant granulocyte colony stimulating factor (GM-CSF) which is given by nose or with a subcutaneous injection which is not approved yet.

The global Pulmonary Alveolar Proteinosis (PAP) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pulmonary Alveolar Proteinosis (PAP).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

Savara

Cleveland Clinic

St. Antonius Hospital Nieuwegein



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Plasmapheresis

Lung transplant

Others



Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Table of Contents



1 Pulmonary Alveolar Proteinosis (PAP) Market Overview

1.1 Product Overview and Scope of Pulmonary Alveolar Proteinosis (PAP)

1.2 Classification of Pulmonary Alveolar Proteinosis (PAP) by Types

1.2.1 Global Pulmonary Alveolar Proteinosis (PAP) Revenue Comparison by Types (2017-2023)

1.2.2 Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Types in 2017

1.2.3 Plasmapheresis

1.2.4 Lung transplant

1.2.5 Others

1.3 Global Pulmonary Alveolar Proteinosis (PAP) Market by Application

1.3.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.4 Global Pulmonary Alveolar Proteinosis (PAP) Market by Regions

1.4.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Pulmonary Alveolar Proteinosis (PAP) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Pulmonary Alveolar Proteinosis (PAP) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pulmonary Alveolar Proteinosis (PAP) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Pulmonary Alveolar Proteinosis (PAP) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pulmonary Alveolar Proteinosis (PAP) Status and Prospect (2013-2023)

1.5 Global Market Size of Pulmonary Alveolar Proteinosis (PAP) (2013-2023)

2 Manufacturers Profiles

2.1 Savara

2.1.1 Business Overview

2.1.2 Pulmonary Alveolar Proteinosis (PAP) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Savara Pulmonary Alveolar Proteinosis (PAP) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Cleveland Clinic

2.2.1 Business Overview

2.2.2 Pulmonary Alveolar Proteinosis (PAP) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cleveland Clinic Pulmonary Alveolar Proteinosis (PAP) Revenue, Gross Margin and Market Share (2016-2017)

2.3 St. Antonius Hospital Nieuwegein

2.3.1 Business Overview

2.3.2 Pulmonary Alveolar Proteinosis (PAP) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 St. Antonius Hospital Nieuwegein Pulmonary Alveolar Proteinosis (PAP) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Pulmonary Alveolar Proteinosis (PAP) Market Competition, by Players

3.1 Global Pulmonary Alveolar Proteinosis (PAP) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Pulmonary Alveolar Proteinosis (PAP) Players Market Share

3.2.2 Top 10 Pulmonary Alveolar Proteinosis (PAP) Players Market Share

3.3 Market Competition Trend

4 Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Regions

4.1 Global Pulmonary Alveolar Proteinosis (PAP) Revenue and Market Share by Regions

4.2 North America Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

4.3 Europe Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

4.5 South America Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

5 North America Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries

5.1 North America Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries (2013-2018)

5.2 USA Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

5.3 Canada Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

5.4 Mexico Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

6 Europe Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries

6.1 Europe Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries (2013-2018)

6.2 Germany Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

6.3 UK Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

6.4 France Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

6.5 Russia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

6.6 Italy Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries

7.1 Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries (2013-2018)

7.2 China Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

7.3 Japan Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

7.4 Korea Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

7.5 India Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

8 South America Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries

8.1 South America Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries (2013-2018)

8.2 Brazil Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

8.3 Argentina Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

8.4 Colombia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Pulmonary Alveolar Proteinosis (PAP) by Countries

9.1 Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

9.3 UAE Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

9.4 Egypt Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

9.6 South Africa Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

10 Global Pulmonary Alveolar Proteinosis (PAP) Market Segment by Type

10.1 Global Pulmonary Alveolar Proteinosis (PAP) Revenue and Market Share by Type (2013-2018)

10.2 Global Pulmonary Alveolar Proteinosis (PAP) Market Forecast by Type (2018-2023)

10.3 Plasmapheresis Revenue Growth Rate (2013-2023)

10.4 Lung transplant Revenue Growth Rate (2013-2023)

10.5 Others Revenue Growth Rate (2013-2023)

11 Global Pulmonary Alveolar Proteinosis (PAP) Market Segment by Application

11.1 Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Application (2013-2018)

11.2 Pulmonary Alveolar Proteinosis (PAP) Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)

11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 Global Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2018-2023)

12.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Size Forecast (2018-2023)

12.2 Global Pulmonary Alveolar Proteinosis (PAP) Market Forecast by Regions (2018-2023)

12.3 North America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

12.4 Europe Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

12.6 South America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Pulmonary Alveolar Proteinosis (PAP) Picture

Table Product Specifications of Pulmonary Alveolar Proteinosis (PAP)

Table Global Pulmonary Alveolar Proteinosis (PAP) and Revenue (Million USD) Market Split by Product Type

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Types in 2017

Figure Plasmapheresis Picture

Figure Lung transplant Picture

Figure Others Picture

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) by Application (2013-2023)

Figure Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Ambulatory Surgical Centers Picture

Figure Diagnostic Centers Picture

Table Global Market Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate (2013-2023)

Table Savara Basic Information, Manufacturing Base and Competitors

Table Savara Pulmonary Alveolar Proteinosis (PAP) Type and Applications

Table Savara Pulmonary Alveolar Proteinosis (PAP) Revenue, Gross Margin and Market Share (2016-2017)

Table Cleveland Clinic Basic Information, Manufacturing Base and Competitors

Table Cleveland Clinic Pulmonary Alveolar Proteinosis (PAP) Type and Applications

Table Cleveland Clinic Pulmonary Alveolar Proteinosis (PAP) Revenue, Gross Margin and Market Share (2016-2017)

Table St. Antonius Hospital Nieuwegein Basic Information, Manufacturing Base and Competitors

Table St. Antonius Hospital Nieuwegein Pulmonary Alveolar Proteinosis (PAP) Type and Applications

Table St. Antonius Hospital Nieuwegein Pulmonary Alveolar Proteinosis (PAP) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) by Players (2013-2018)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Players (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Players in 2016

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Players in 2017

Figure Global Top 5 Players Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share in 2017

Figure Global Top 10 Players Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share in 2017

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) by Regions (2013-2018)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Regions (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Regions (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Regions in 2017

Figure North America Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Europe Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure South America Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Table North America Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries (2013-2018)

Table North America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure North America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure North America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries in 2017

Figure USA Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Canada Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Mexico Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Table Europe Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure Europe Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries in 2017

Figure Germany Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure UK Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure France Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Russia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Italy Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries in 2017

Figure China Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Japan Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Korea Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure India Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Table South America Pulmonary Alveolar Proteinosis (PAP) Revenue by Countries (2013-2018)

Table South America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure South America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure South America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries in 2017

Figure Brazil Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Argentina Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Colombia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure UAE Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Egypt Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure Nigeria Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Figure South Africa Pulmonary Alveolar Proteinosis (PAP) Revenue and Growth Rate (2013-2018)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) by Type (2013-2018)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Type (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Type (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Type in 2017

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue Forecast by Type (2018-2023)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Share Forecast by Type (2018-2023)

Figure Global Plasmapheresis Revenue Growth Rate (2013-2018)

Figure Global Lung transplant Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue by Application (2013-2018)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Application (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Application (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Share by Application in 2017

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue Forecast by Application (2018-2023)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)

Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Pulmonary Alveolar Proteinosis (PAP) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

Figure Europe Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

Figure South America Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Pulmonary Alveolar Proteinosis (PAP) Revenue Market Forecast (2018-2023)

Choose License Type